http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20150101693-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b6171684de68ce62ef3fbf1655618249 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2014-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06521cefae1c9f97714a7b50f3915e4c |
| publicationDate | 2015-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20150101693-A |
| titleOfInvention | Composition for metastasis inhibition of liver cancer containing expression inhibitor of HBx(Hepatitis B virus X) Protein |
| abstract | The present invention relates to a composition for inhibiting the expression of hepatocellular carcinoma (HBx) in hepatocellular carcinoma cells. More particularly, the present invention relates to a composition for inhibiting the expression of hepatocellular carcinoma (HBx) epithelial-mesenchymal transition), thereby exhibiting an inhibitory effect on liver cancer metastasis. Since the HBx expression inhibitor according to the present invention can inhibit the hepatocellular carcinoma metastasis by suppressing the epithelial-mesenchymal transition (EMT) from the epithelial cells of hepatocellular carcinoma in the CD44-positive hepatocellular carcinoma cell line, And the like. |
| priorityDate | 2014-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 170.